TagsDiabetes 
An Update on the Role of SGLT-2 Inhibitor in the KDIGO Guideline on the Management of CKD

The Burden of Chronic Kidney Disease Chronic kidney disease (CKD) is one of the most prominent causes of death and suffering in the 21 st century. The number of patients affected by CKD has substantially increased with an estimate of 843.6 million i...

Oct 26, 2023
Knowing Who and When Diabetes Education Should Best Target

Previous research has shown a relationship between weight gain around holiday seasons and seasonal variations in lifestyle behaviours and eating patterns. As glycaemic outcome is also to directly affected by the lifestyle behaviours and eating patte...

Oct 24, 2023
Preserving Kidney Health in Type 2 Diabetes Mellitus

Early Blood Glucose Control as the Key to Preventing and Delaying Progression DM is the leading cause of CKD worldwide. The Hong Kong Central Renal Registry reported that diabetic nephropathy (DN) accounts for nearly 50% of patients who undergo dial...

Sep 27, 2021
Finerenone Lowers the Risk of CKD Progression and Cardiovascular Events in Patient with Type 2 Diabetes

Finerenone, a selective mineralocorticoid receptor antagonist, has been proven to reduce albuminuria in patients with chronic kidney disease (CKD) and type 2 diabetes in previous trials. Recently, a clinical trial reported the long-term effects of f...

Dec 23, 2020
Beyond Prevention of Stroke and Systemic Embolism - Managing the Unmet Needs in Diabetes Mellitus with Atrial Fibrillation

The Complication of T2DM with AF Prolonged elevation in blood glucose level would result in various health complications including cardiovascular diseases (CVDs) and kidney diseases 4 . In particular, T2DM was found to be a strong and independent ri...

Dec 15, 2020
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes Mellitus (T2DM)

The impact of blood glucose control on the degree of required medical interventions and mortality in patients with COVID-19 and T2DM remains uncertain. A recent retrospective study involving 7337 patients with COVID-19, among which 952 cases had pre...

Jun 10, 2020
The Endocrinology, Diabetes & Metabolism Hong Kong (EDMHK) 2nd Annual Meeting

The Endocrinology, Diabetes & Metabolism Hong Kong (EDMHK) 2 nd Annual Meeting The Endocrinology, Diabetes & Metabolism Hong Kong (EDMHK) 2019 meeting held on 26th – 27th October 2019 was jointly organised by the University of Hong Kon...

Dec 16, 2019
Insulin Degludec: Overcome the Barrier of Insulin Therapy in Diabetes Management

Unique mechanism with pharmacodynamic stability In order to achieve recommended glycaemic targets and minimise the risk of hypoglycaemia, low variability in glucose-lowering effect is definitely needed. However, the pharmacodynamic effects of exogen...

Dec 16, 2019
Beyond Glycaemic Management: Toward Cardiovascular Risk Prevention in Diabetes

Far More than Glycaemic Control Diabetes mellitus (DM) is common, affecting approximately 10% of Hong Kong adult population 1 . Good control to prevent vascular complications from diabetes is one of the key issues to tackle in the long-term manageme...

Dec 16, 2019
Managing Diabetic Peripheral Neuropathy with Topical Therapeutics

Managing Diabetic Peripheral Neuropathy with Topical Therapeutics Neuropathic pain is a disorder of the central and peripheral nervous system resulting from a lesion or disease. In diabetic patients, neuropathic pain (referred to as diabetic polyneu...

Dec 16, 2019
Gestational Diabetes Mellitus: The Challenges and Management During and After Pregnancy

Gestational Diabetes Mellitus: The Challenges and Management During and After Pregnancy Gestational diabetes mellitus (GDM) is a serious pregnancy complication, and according to the International Diabetes Federation (IDF), the disease affects approx...

Dec 16, 2019
Therapeutic Potential of Multitasking Factors for Beta-cells in Type 2 Diabetes Mellitus

Therapeutic Potential of Multitasking Factors for Beta-cells in Type 2 Diabetes Mellitus Type 2 diabetes mellitus (T2DM) is clinically diagnosed by elevated plasma glucose levels. However, loss of pancreatic beta-cell function occurs before diabetes...

Dec 16, 2019